Reconstruction and Trauma News and Latest Research
- No significant volume-outcome link for AMS 800 sphincter after adjustment in European registry Prospective · Eur Urol Focus · 2026-11-18
Among 684 patients in the prospective SATURN registry, crude 1-year revision and complication rates varied by center volume, but no statistically significant association remained after multivariable adjustment for patient and procedure factors.
Why it matters: Suggests center volume alone may not explain AMS 800 outcome variation once case mix is accounted for.
- Longer oral mucosa grafts for urethroplasty linked to more donor-site morbidity Retrospective · World J Urol · 2026-11-15
Among 304 patients who underwent oral mucosa graft urethroplasty (115 with strictures ≤5 cm, 189 with strictures >5 cm), 21.1% reported at least one significant oral complication on follow-up questionnaires (up to 12 years). Oral numbness occurred in 17.1% overall, more often in the longer-stricture group (20.1% vs 12.2%), and discomfort while smiling or laughing was significantly more frequent in that group (7.4% vs 0.9%, p=0.01), with trends toward more pain, trismus, and eating difficulty that did not all reach statistical significance.
Why it matters: These findings support surgical planning that minimizes graft length and favors buccal-only harvest sites when feasible to limit long-term donor-site symptoms.
- Pump-preserving AUS revision feasible when pump is functioning normally Prospective · Urology · 2026-11-09
In a prospective single-center series of 60 artificial urinary sphincter revisions, surgeons preserved a normally functioning pump in all cases, with no pump-related complications and earlier device reactivation (2 weeks vs standard 6 weeks).
Why it matters: Suggests pump preservation may be a feasible option in selected AUS revisions to limit scrotal dissection and shorten reactivation time.
- Allium covered stents beat Memokath for radiation ureteral strictures but carry unique fistula risk Retrospective · World J Urol · 2026-11-09
Among 149 patients (205 ureteral units) treated for radiation-induced ureteral strictures, Allium stents showed higher 12- and 36-month primary success (75.9% vs 49.3% and 33.2% vs 23.2%) and cumulative success (96.3% vs 91.5% at 12 months, 64.0% vs 28.2% at 36 months) compared with Memokath stents, with median primary success duration of 30 vs 12 months (log-rank P < 0.001); ureteral fistulas occurred in 11 patients, exclusively in the Allium group.
Why it matters: For refractory radiation strictures, covered self-expandable stents may offer meaningfully longer patency than thermo-expandable stents, though the fistula signal tied to larger caliber and tandem stenting warrants careful sizing and patient selection.
- Meta-analysis: urethroplasty for post-BPH surgery bulbomembranous strictures shows 90% pooled patency Meta-analysis · BJU Int · 2026-11-01
A systematic review and meta-analysis of 417 patients from 9 observational studies found an overall pooled patency rate of 90% for urethroplasty after bulbomembranous strictures following BPH surgery, with patency around 87-94% depending on technique, though definitions of patency and continence varied widely.
Why it matters: Provides pooled benchmark patency rates for a challenging post-BPH stricture population, though heterogeneous outcome definitions and moderate-to-serious risk of bias limit certainty.
- Retrospective series reports outcomes after revision of difficult-to-catheterize continent channels Retrospective · Neurourol Urodyn · 2026-10-29
In a single-institution retrospective review of 45 adults undergoing 54 continent catheterizable channel revisions, 76% were free from reoperation at median 46-month follow-up, with success rates similar across suprafascial, subfascial, and replacement techniques.
Why it matters: Is hypothesis generating for channel revision technique selection given single-center retrospective design without randomized comparison.
- Meta-analysis: PAMORAs linked to faster bowel recovery after radical cystectomy Meta-analysis · Transl Androl Urol · 2026-10-14
A systematic review and meta-analysis found that adding peripherally acting mu-opioid receptor antagonists (alvimopan, naloxegol, methylnaltrexone) to enhanced recovery pathways after radical cystectomy was associated with shortened time to first flatus and improved postoperative GI recovery versus enhanced recovery alone, though certainty of evidence varied and data specific to cystectomy remain limited and…
Why it matters: Suggests PAMORAs may help reduce postoperative ileus after cystectomy, but evidence quality is variable and more robust data are needed before routine incorporation into enhanced recovery protocols.
Urology clinical trials · Urology podcasts · Urology videos · Meetings · Daily edition archive
Loading today's edition…